Key takeaways
- Health Canada has authorized six medications for chronic weight management: semaglutide, tirzepatide, liraglutide, naltrexone/bupropion and setmelanotide, all listed in the 2025 CMAJ guideline
- GLP-1 is a hormone the body produces naturally that's involved in appetite and digestion; medications in this class are prescribed only after a practitioner's assessment
- Timelines vary from person to person, and the full dose-escalation schedule for injectable GLP-1 medications typically runs five to six months
- Gastrointestinal side effects like nausea and diarrhea are most prominent during dose escalation and diminish as the body adjusts
- One-year persistence with GLP-1 therapy ranges from 32% to 50%; behavioural support and lifestyle changes alongside medication are widely recommended as part of treatment
- Obesity is a chronic condition, so treatment is often approached on an ongoing basis, the way conditions like hypertension are managed
Roughly three million Canadians now use GLP-1 medications, and that number keeps climbing. Starting a weight health medication raises a lot of questions. Knowing what to expect, including the early side effects, the timeline and the lifestyle shifts ahead, makes those first weeks easier to navigate.
Understanding weight health medications
Weight health medications come in several classes, and they aren't interchangeable. Some are injectable and others are oral. Which one is appropriate for a given person depends on their full health picture, which a practitioner assesses individually.
How these medications differ from one another
Medications in this category vary by class, route and how often they're taken. They also differ in the dosing schedule a practitioner follows when starting treatment. How a given medication affects someone differs from person to person, which is one reason a practitioner reviews your response over time.
How GLP-1 medications relate to a natural hormone
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases naturally after eating. It prompts insulin release, moderates glucagon and sends satiety signals to the brain. GLP-1 receptor agonists are medications that act on those same receptors. A practitioner can walk you through how this works and what it may mean for your care.
Why nausea is common early on
With these medications, food moves more slowly from the stomach into the small intestine. That's part of why nausea is common early on, since the stomach holds food longer than it's used to. These effects tend to be most noticeable during the first weeks and after each dose increase.
Common medication classes and types
The 2025 CMAJ guideline update lists six Health Canada-approved options across several classes:
| Medication | Class | Route |
| Semaglutide | GLP-1 RA | Injectable |
| Tirzepatide | GIP/GLP-1 dual agonist | Injectable |
| Liraglutide | GLP-1 RA | Injectable |
| Naltrexone/bupropion | Opioid antagonist/NDRI | Oral |
| Orlistat | Lipase inhibitor | Oral |
Starting your medication: the assessment process
Before any prescription gets written, a Canadian-licensed doctor or nurse practitioner conducts a clinical assessment. It's not just a formality. It's where the practitioner screens for contraindications, reviews your full medication list and considers which option is most appropriate for your health profile.
What to discuss with a practitioner
Be upfront about everything: current medications, supplements, mental health history and any personal or family history of thyroid conditions, pancreatitis or eating disorders. Practitioners ask open-ended questions to surface these risks, and the more you share, the more informed the prescribing decision can be. Our network of Canadian-licensed practitioners gives you space to share your full picture through secure text, audio or video call, so important details don't get overlooked.
What the medical evaluation covers
A practitioner looks at your full health picture, not one number: your medical history, other conditions, cardiovascular risk, kidney function and any history of gastrointestinal conditions. Whether a medication is appropriate is a clinical decision made at the end of that assessment.
Health conditions a practitioner screens for
Widely accepted contraindications include a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN2) and a personal history of pancreatitis. Active or past eating disorders are also a flag, since appetite changes can complicate recovery and need careful screening. Product labels for this class carry a black-box warning, and a practitioner goes through all of it with you before prescribing.
How weight health medications interact with other medications and supplements
Medication interactions are easy to overlook when you're focused on weight goals, but some combinations can affect safety or how a medication is absorbed. It's worth reviewing your full list with a practitioner or pharmacist.
Common medication interactions to discuss with a pharmacist
Slowed gastric emptying can affect how quickly oral medications are absorbed. If you take oral contraceptives, thyroid medications or medications with narrow therapeutic windows, like warfarin or certain seizure medications, a practitioner or pharmacist needs to know, since timing adjustments may be necessary. A pharmacist can review your existing list before you start.
Supplements and over-the-counter products to flag before starting
Fat-soluble vitamins (A, D, E, K) are worth flagging, particularly with orlistat, because of how it affects fat absorption. Iron, B12 and calcium supplements may also need timing adjustments depending on your regimen. Flag everything, including herbal products, at your first visit.
Your first weeks: titration and adjustment
The first four to eight weeks are the adjustment phase, and they're often the hardest. Dose escalation schedules are deliberately slow. That's by design. Moving too quickly is the most common route to side effects severe enough to make people want to stop.
Understanding dose escalation schedules
Most injectable GLP-1 medications start at a low dose and step up in stages, typically every few weeks, at a practitioner's direction. The exact schedule depends on the specific medication and how your body responds. This gradual approach gives your digestive system time to adapt between steps. Virtual check-ins during this period let you flag early reactions, so adjustments can be made without waiting for an in-person visit.
What happens during the initial adjustment period
Energy levels may dip. Food preferences often shift, and foods that once appealed can suddenly seem less so. Some people notice mild fatigue or headache in the first week or two. These are common during adjustment and usually aren't reasons to stop, though a practitioner can advise if anything feels off.
What the first weeks typically look like
Experiences in the first weeks vary widely from person to person, and any changes early on are typically gradual rather than dramatic. Individual factors, including starting point, metabolism and day-to-day habits, all play a role, which is why a practitioner tracks how you're doing rather than working to a fixed timeline.
Understanding the treatment timeline
The full dose-escalation schedule runs roughly five to six months for most injectable GLP-1 medications. Patience matters here.
Managing side effects and symptoms
Gastrointestinal side effects are the main reason people stop early. Knowing when they tend to appear and what to do about them helps many people get through the adjustment phase.
Common side effects and when they typically appear
Side effects are most common during the initial dose-escalation phase, particularly in the first four to eight weeks and after each step up. They tend to ease as your body adjusts between steps.
Common gastrointestinal side effects
Nausea is the most common side effect, with rates varying by dose based on clinical trial data. Diarrhea affects some people as well. Constipation, vomiting and bloating can also occur.
Strategies for managing side effects
Practitioners often recommend eating smaller, low-fat, low-fibre meals at consistent intervals rather than large, irregular ones. Stay well hydrated, which also helps with constipation. Eat slowly, avoid lying down right after meals and time your injection away from mealtimes. For people who are struggling, a practitioner may suggest over-the-counter options for nausea or temporarily pause the dose increase.
When to connect with a practitioner
Reach out promptly if you have persistent vomiting that keeps you from holding fluids down, severe abdominal pain that radiates to the back (a possible pancreatitis signal) or significant mood changes. Don't wait for your next scheduled visit. With on-demand virtual access, you can connect with a Canadian-licensed practitioner quickly and skip the walk-in clinic when something doesn't feel right.
If you're experiencing a medical emergency (like trouble breathing), you should call 911 or head to the nearest ER.
Lifestyle changes and medication use
Medication is one part of a broader approach, not a standalone fix. Research consistently points to the value of pairing treatment with dietary changes and physical activity, and practitioners generally recommend addressing both alongside any medication.
How diet and physical activity work alongside medication
Guidance published in December 2025 puts specific emphasis on lifestyle changes as a co-intervention alongside medication rather than a replacement for it. Resistance training matters in particular because it helps preserve muscle mass. A common target is at least 150 minutes of moderate activity a week.
Adjusting eating patterns and food choices
If portions feel smaller during treatment, front-loading protein at each meal can help protect muscle. Current guidance suggests roughly 1.2 to 1.6 g/kg/day of protein, with a minimum of about 0.4 to 0.5 g/kg/day. Sleep matters too: poor sleep affects the hormones that regulate hunger.
What foods to avoid when taking weight health medication
High-fat, greasy foods can make nausea worse, so it helps to limit them, especially early in dose escalation. Alcohol can worsen GI symptoms. Highly processed foods and fast food tend to work against the eating patterns that treatment is meant to support. Focus instead on lean proteins, vegetables and whole grains.
Psychological and behavioural support during treatment
Why behavioural support is part of treatment
One-year persistence with GLP-1 therapy ranges from 32% to 50%, which points to a clear theme: medication on its own is rarely the whole picture. Building habits alongside treatment, including structured eating patterns, stress management and a steadier relationship with food, is widely recommended as part of care. Behavioural support helps turn those habits into ones that last.
Types of support to consider alongside your medication
A registered dietitian can help structure protein intake and meal timing. A therapist or counsellor familiar with eating disorder signs and weight health can support emotional eating patterns. Group programs can help with staying consistent. Think of these as part of treatment, not extras.
How individual factors shape your experience
How age, sex and metabolism factor in
Response to these medications varies with factors like age, sex and metabolism. Older adults may notice changes more gradually, partly because of metabolic rate and muscle mass. Hormonal differences between sexes can influence how the body responds. Starting point matters too. Outcomes differ from person to person, which is why a practitioner monitors your individual response over time.
Why responses vary from person to person
Several things shape how someone responds: genetics, gut microbiome, sleep quality, activity level and how consistently the medication is taken. The link between sleep and metabolic function is well established. None of this is fully predictable, which is why two people on the same medication can have very different experiences, and why ongoing follow-up matters.
Ongoing monitoring and follow-up care
Regular follow-up isn't optional. It's where a practitioner catches problems early and makes adjustments before small issues become reasons to stop.
Regular check-ins and health assessments
Most practitioners schedule check-ins every four to six weeks during dose escalation, then quarterly once a maintenance dose is established. These visits cover weight, blood pressure and any side effects. Virtual care makes consistent follow-up easier to keep up with, with no travel, and you can skip the walk-in clinic.
Tracking your response and adjusting treatment
Weight changes are tracked alongside other markers: waist circumference, energy levels and any shifts in co-existing conditions like blood pressure or blood sugar. If progress plateaus, a practitioner may adjust the dose or consider whether a different medication is more appropriate, following a clinical assessment.
Monitoring for nutritional deficiencies and long-term safety
Smaller portions over months can mean lower intake of key micronutrients. Regular lab work should screen for B12 and iron, since deficiencies are possible with sustained caloric restriction. Both Health Canada and Obesity Canada recommend monitoring for longer-term safety signals during extended GLP-1 use. Bringing up any digestive changes with a practitioner at each visit is a good habit.
Extended use considerations
What a practitioner monitors during extended use
Long-term use is something a practitioner reviews with you over time, taking your overall health, any other conditions and how you're tolerating treatment into account. Product labels carry warnings that a practitioner and a pharmacist review before you start and as treatment continues.
Potential complications associated with extended use
Extended use calls for monitoring for gallbladder issues, along with muscle loss if protein intake falls short and possible mood changes. A practitioner monitors for these over time, which is part of why ongoing follow-up matters.
Cost, coverage and access in Canada
Medication costs and pricing in Canada
Out-of-pocket costs vary by medication, and the figures below don't include dispensing fees:
- Semaglutide (Wegovy): about CAD $540 to $570 per pen, roughly one pen per month
- Liraglutide (Saxenda): about CAD $400 to $600 per month
- Naltrexone/bupropion (Contrave): about CAD $225 to $400 per month
- Orlistat (Xenical): about CAD $210 to $250 for an 84-capsule supply
How dosage can affect cost
Some medications have dosage-dependent pricing, so a lower starter dose can cost less than a higher maintenance dose. Tirzepatide (Zepbound), for example, carries a manufacturer list price of about CAD $300 per four-week supply at the 2.5 mg and 5 mg starting doses, rising to $420 at 7.5 mg and 10 mg and $540 at the 12.5 mg and 15 mg maintenance doses, following Eli Lilly's price reduction effective 29 December 2025. Pricing across the category continues to shift as more options reach the Canadian market, so it's worth checking current costs with a pharmacist.
Insurance coverage and benefit plan options
Ozempic has become the single largest driver of growth in Canadian public drug plan spending, accounting for roughly $807 million of $20.1 billion. Most public plans cover GLP-1s for diabetes rather than weight management. On the private side, 37% of Canadian employers cover GLP-1s for both diabetes and weight loss, up from 31% in 2025, while 51% cover for diabetes only. Coverage varies by plan, so check your formulary directly and ask about prior authorization requirements.
Long-term use and discontinuation
How long will you need to take weight health medication?
For many people, weight health medication is approached as a long-term treatment rather than a short-term fix. Obesity is a chronic condition, and clinicians often manage it on an ongoing basis for those who are tolerating treatment well. Staying on medication isn't a sign you've failed. It's the same logic that applies to managing blood pressure or cholesterol.
What to expect if you stop taking your medication
Appetite and cravings tend to return as the medication clears the system, often within days to weeks. That's why practitioners generally recommend building eating and activity habits during treatment rather than after it, and why stopping is a decision to work through with a practitioner rather than on your own.
What to plan for before stopping weight health medication
The key is established lifestyle habits: consistent eating patterns, adequate protein intake, regular physical activity and sustained behavioural changes that hold on their own, without relying on the medication. Building those habits during treatment, rather than leaving them until after, is what practitioners generally advise. If you're thinking about stopping, connect with a Canadian-licensed practitioner first to build a tapering and transition plan. Our network of practitioners can work through that decision with you via secure text, audio or video call, at your own pace. The right approach depends on the specific medication. A daily injectable, for example, may be tapered differently than an oral one, and some medications carry considerations a practitioner will want to review before you stop.
Prescription medications are only available if deemed appropriate by a Canadian-licensed healthcare practitioner following a clinical assessment. Individual results may vary. This content does not replace medical advice. Medication costs are not included; if prescribed, the cost depends on the medication and dosage, and prices and quantities may vary.
Conclusion
Knowing what to expect, from the first weeks of adjustment to long-term follow-up, is what helps people stay with treatment when things get uncomfortable. GI side effects are common early on and tend to ease between dose steps. The process takes months, not weeks, and the lifestyle work alongside medication is a big part of care. Connect with a Canadian-licensed practitioner on Maple for a clinical assessment to explore your options.
FAQ
Q: How long does it take to get started on weight health medication?
Experiences vary from person to person. The full dose-escalation schedule typically runs five to six months, and a practitioner tracks your individual response throughout.
Q: Do I have to stay on the medication long-term?
Obesity is a chronic condition, so it's often managed on an ongoing basis. Whether to continue, adjust or stop is a decision made with a Canadian-licensed practitioner following a clinical assessment.
Q: What does it cost in Canada?
Out-of-pocket costs vary by medication and dosage and don't include dispensing fees. Coverage differs across public and employer plans, so check your benefits formulary directly.
References
- CMAJ: 2025 clinical practice guideline update on obesity management in adults
- CBC News: how many Canadians are using GLP-1 medications
- PubMed Central: multinational cohort study on GLP-1 receptor agonists
- AJMC: WHO guidance on GLP-1 medications and obesity care
- JMCP: one-year persistence with GLP-1 therapy
- Canadian Medical Association: GLP-1 medications in Canada
- Insurance Business Canada: GLP-1 costs and Canadian medication plans
